𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Viral and host factors in early hepatitis C virus infection

✍ Scribed by James W. Mosley; Eva A. Operskalski; Leslie H. Tobler; William W. Andrews; Bruce Phelps; Janel Dockter; Cristina Giachetti; Michael P. Busch


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
130 KB
Volume
42
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Since 1980, the Transfusion-transmitted Viruses Study (TTVS) (1974-1980) has continued to maintain its computerized database and stored sera to enable ongoing study of new transfusion events since the 1970s. Most recently, we have used this resource to study parameters of acute hepatitis C virus (HCV) infection among 94 donor-recipient pairs in which there was transmission. In addition, frequent recipient observations permitted further characterization of the early phase of the infection's course. Donor RNA load ranged from 3.7 to 3,160,000 IU/mL. Onset of recipient viremia was judged from a total of 67 sera collected during the 4th through 8th days posttransfusion; only 2 of the 67 sera were still RNA nonreactive by that time. The recipients' latent periods to an alanine aminotransferase (ALT) elevation of > or =90 IU/L ranged from 6 to 112 days (median, 46 days) and was shorter with higher donor RNA levels. Descriptors of the recipient's illness showed several strongly positive and negative correlations. The latent period tended to be shorter in the 37% of cases that were clinically overt. Attributes of donors with genotypes 1 and non-1 and subtypes 1a and 1b did not differ significantly. Recipients with genotype 1 strains had shorter latent intervals than non-1 strains. On multivariate analysis, latent period was significantly associated (negatively) only with the highest ALT level during the first 120 days of follow-up (P = .014). In conclusion, host factors are more important determinants of acute HCV infection dynamics than virus-associated factors.


πŸ“œ SIMILAR VOLUMES


Hepatitis C viral quasispecies and liver
✍ J Hayashi; Y Kishihara; K Yamaji; N Furusyo; T Yamamoto; Y Pae; Y Etoh; H Ikemat πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 193 KB πŸ‘ 2 views

To clarify the virological differences in patients with chronic hepatitis C virus (HCV) infection with and without liver damage, we assessed HCV markers in 306 patients from a rural area of Japan. Genotypes of HCV RNA were determined by polymerase chain reaction, and levels of RNA were determined by

Cytotoxic T lymphocyte response and vira
✍ K Hiroishi; H Kita; M Kojima; H Okamoto; T Moriyama; T Kaneko; T Ishikawa; S Ohn πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 237 KB πŸ‘ 2 views

liver-infiltrating lymphocytes 4 of patients with chronic hepa-A cytotoxic T lymphocyte (CTL) response to the hepatitis C, the role of CTL responses in HCV infection is untitis C virus (HCV) nucleoprotein residues 88-96 that are known. HCV infection frequently persists and is implicated the minimal

Ethnic differences in viral dominance pa
✍ Long H. Nguyen; Steve Ko; Shane S. Wong; Pelu S. Tran; Huy N. Trinh; Ruel T. Gar πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 225 KB πŸ‘ 2 views

Studies of hepatitis B virus (HBV)/hepatitis C virus (HCV) dual infection are limited. Most are small, conducted outside the United States, and compare dual infection with HCV monoinfection. The goal of this study was to characterize HBV/HCV dual infection in a large multiethnic, matched, case-contr

Individualized treatment strategy accord
✍ Thomas Berg; Viola Weich; Gerlinde Teuber; Hartwig Klinker; Bernd MΓΆller; Jens R πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 394 KB πŸ‘ 1 views

Individualized treatment on the basis of early viral kinetics has been discussed to optimize antiviral therapy in chronic hepatitis C virus (HCV) infection. Individually tailored reduction in treatment duration in HCV type 1-infected patients represents one possible strategy. Four hundred thirty-thr